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Purpose.Thisisasecondaryanalysisofpreviouslypublisheddatatoinvestigatetheeﬀectsofelectricalmusclestimulation(EMS)on
strength of various muscle groups in critically ill patients. Methods. One hundred forty-two consecutive patients, with APACHE II
score ≥ 13, were randomly assigned to the EMS or the control group. EMS sessions were applied daily on vastus lateralis, vastus
medialis,andperoneuslongusofbothlowerextremities.Variousmusclegroupswereevaluated withtheMedical ResearchCouncil
(MRC)scaleformusclestrength.Handgripstrengthassessmentwasalsoemployed.Results.TwentyfourpatientsintheEMSgroup
and 28 patients in the control group were ﬁnally evaluated. EMS patients achieved higher MRC scores than controls (P ≤ 0.05) in
wrist ﬂexion, hip ﬂexion, knee extension, and ankle dorsiﬂexion. Collectively, the EMS group performed higher (P<0.01) in the
l e g sa n do v e r a l l .H a n d g r i ps t r e n g t hc o r r e l a t e d( P ≤ 0.01) with the upper and lower extremities’ muscle strength and the overall
MRC scores. Conclusions. EMS has beneﬁcial eﬀects on the strength of critically ill patients mainly aﬀecting muscle groups stimu-
lated, while it may also aﬀect muscle groups not involved presenting itself as a potential eﬀective means of muscle strength
preservation and early mobilization in this patient population.
1.Introduction
Intensive Care Unit acquired weakness (ICU-AW) is a neu-
romuscular complication frequently observed in survivors of
acute critical illness. It is characterized by profound muscle
weakness [1] and is associated with delayed weaning from
mechanical ventilation [2]. Risk factors include systemic
inﬂammatory response and sepsis [3, 4], several medications
[5], prolonged immobility and bed rest [5], and severity of
organ dysfunction [6]. Apart from controlling for potentially
reversible risk factors and subsequent adjustment of therapy,
no other eﬀective means have been suggested so far for the
prevention of ICU-AW.
Prevention of ICU-AW is also related to early mobiliza-
tion and rehabilitation in the ICU. Recent studies have de-
monstrated that early mobilization can be safe and feasible,
with a potential reduction in short-term physical impair-
ment [7, 8]. However, patient’s cooperation is necessary for
an essential intervention to be applied.
Electrical muscle stimulation (EMS) is a form of exercise
and mobilization that does not require active participation
and can be applied to immobilized subjects. EMS has
been shown to be beneﬁcial in patients with chronic heart
failure(CHF)[9]andchronicobstructivepulmonarydisease
(COPD) [10, 11], as well as ICU and hospital inpatients [12–
14].
We have previously shown that EMS in ICU patients
induces a systemic acute eﬀect on the microcirculation of
muscles not applied [15] and preserves the mass of muscle
groups applied [16]. We have also found that EMS prevents
ICU-AW, which was diagnosed in 12.5% of the EMS group
in comparison to 39.3% of the control group and results2 Critical Care Research and Practice
in shorter duration of weaning from mechanical ventilation
[17]. However, the EMS eﬀects on the strength of individual
muscle groups are not known.
Therefore, the primary aim was the posthoc analysis of
recently published data [17] to investigate the eﬀect of EMS
on the strength of various muscle groups in critically ill
patients. Secondary aims were to establish the relationship
between diﬀerent tests of muscle strength evaluation and to
explore the technical issues in relation to muscle strength
assessment in the ICU setting.
2.MaterialsandMethods
2.1. Patients. All patients consecutively admitted to the mul-
tidisciplinary university ICU of Evangelismos Hospital dur-
ing the study period (September 2007–June 2009) were con-
sidered for inclusion. Exclusion criteria were age under 18,
pregnancy,obesity(BMI>35kg/m2),preexistingneuromus-
cular disease (e.g., myasthenia gravis, Guillain-Barr´ e), dis-
eases with systemic vascular involvement such as lupus ery-
thematosus,technicalrestrictionsthatdidnotallowtheimp-
lementation of EMS such as bone fractures or skin lesions
(e.g., burns), and end-stage malignancy. Patients with car-
diac pacemakers and those with an ICU stay of less than
48 hours were also excluded. Patients with the diagnosis of
brain death were not considered for inclusion. The study was
approvedbytheScientiﬁcCouncilandtheEthicsCommittee
of “Evangelismos” Hospital in accordance with the ethical
standards set by the Declaration of Helsinki, and written
informed consent was given by family members of all the
patients included in the study.
2.2. Study Design and Randomization. This was a posthoc
analysis of a randomized parallel intervention clinical trial
already reported [17]. On the second day after admission (24
to 48 hours after admission), patients with acute physiology
and chronic health evaluation (APACHE) II score ≥ 13 were
randomlyassignedtotheinterventiongroup(EMSgroup)or
the control group. Randomized stratiﬁcation was performed
upon age (≤ or >50 years of age, which is the median value
of our ICU patients’ age) and gender (male/female). Patients
assigned to the EMS group received daily EMS sessions of
both lower extremities starting from the second day after
admissionuntilICUdischargeandMRCevaluation.Patients
in the control group did not receive sham EMS. EMS was
applied in addition to the usual ICU care.
2.3. Electrical Muscle Stimulation. EMS (45Hz, 400µsec,
12secon–6secoﬀ, 0.8secramp up/ramp down duration)
was implemented simultaneously on vastus lateralis, vastus
medialis, and peroneus longus of both lower extremities.
After shaving (in the case of hairy skin) and skin cleaning,
rectangular electrodes (90 × 50mm) were placed on the
motor points of the aforementioned muscle groups of both
legs (Rehab 4 Pro, CEFAR Medical AB, Malm¨ o, Sweden).
Amplitude was set at levels able to cause visible contractions.
In case of doubt, contraction was conﬁrmed by palpation of
the muscles involved. During the session, the angle of the
patients’ knee joint was approximately 40◦ (0◦ corresponds
to full knee extension). EMS sessions lasted for 55min
including 5 minutes for warm up and 5 minutes for recovery.
Themeannumberandproportionofsessionsthattookplace
was 8 ±6a n d8 2±20%.
2.4. MRC Muscle Strength Scale. The Medical Research
Council (MRC) score for clinical assessment of muscle
strengthwasusedfortheevaluationofstrengthandthediag-
nosis of ICU-AW. MRC scale application has been previously
d e s c r i b e di nd e t a i l[ 17]. In short, after interruption of
sedation,MRCwasassessedinthreemusclegroupsinallfour
limbs on the day the patients had a level of consciousness
adequate to cooperate. The movements assessed were shoul-
der abduction, forearm ﬂexion, wrist ﬂexion, hip ﬂexion,
kneeextension,andankledorsiﬂexion[18].Forthediagnosis
of ICU-AW, the cutoﬀ point of 48 was selected [2]. The
MRC score evaluation was performed by two independent
investigators, not blinded to patients’ allocation and familiar
with this technique, who provided written MRC scoring for
each muscle group. The mean value of the MRC score of
the two investigators was used in data analysis. Manual
muscle strength testing has been observed to have very good
interobserver reliability [19].
2.5. Handgrip Application. Handgrip dynamometry (Lafa-
yette 78011, Lafayette Instrument Co. Inc., Lafayette, IN,
USA) was applied to a subgroup of consecutive patients to
evaluate handgrip strength as an index of upper-limb muscle
strength. It was administered immediately after MRC assess-
ment in both hands. Patients were seated nearly upright,
positionedat140◦ (180◦ correspondstothesupineposition).
The patients’ arm was positioned at their side, parallel to
the sagittal plane of the body, laid against the bed with
the elbow at 90◦, and supported by the examiner if neces-
sary. These angles were measured and conﬁrmed with a
goniometer. During each trial, patients were continuously
encouraged to “squeeze as forcefully as possible” for 4-5
seconds. Five trials were allowed for each hand alternatively,
with a pause of 60sec between each one. The hand with the
higher performance was considered for analysis. Once two
eﬀorts diﬀered by less than 5% (with a minimum diﬀerence
of1kg),thelargerofthetwoeﬀortswasconsideredthemaxi-
mum value and used for the assessment. Before the mea-
surements, patients were familiarized with the procedure.
All measurements were performed by the same experienced
examiner, who was not blinded to the patients’ allocation.
Handgrip dynamometry absolute values were also trans-
formed to relative values (% predicted), according to the
norms provided by Schl¨ ussel et al. [20].
2.6. Statistical Analysis. Power analysis was performed prior
to the study initiation, and it was based on a previous
epidemiological study from our ICU [4]. Normality of dis-
tribution was checked by employing Kolmogorov-Smirnov
or Shapiro-Wilk test. Unpaired Student’s t-test or Mann-
Whitney U test (in case of not normal distribution) wasCritical Care Research and Practice 3
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Figure 1: Flow chart diagram of the patients admitted to the ICU during the 30-month study period. NMBAs: neuromuscular blocking
agents.
employed for between-group comparisons. Categorical vari-
ables were compared by chi-square test. The Spearman’s r
coeﬃcient was used for correlations. Between-group com-
parisons in relation to handgrip dynamometry were made
with analysis of covariance (ANCOVA) to adjust for age and
gender. The “95% limits of agreement” method was used for
comparison of dominant and nondominant handgrip dyna-
mometry. One-way repeated measures analysis of variance
(ANOVA) was made to compare handgrip performance over
the 5 trials.
MRC measures are reported as median (25th–75th per-
centiles). All other variables are presented as mean±SD.
P values ≤0.05 were considered statistically signiﬁcant.
3. Results
Patient recruitment ﬂow chart, as previously reported [17],
is presented in Figure 1. Fifty two patients were ﬁnally eva-
luated, 24 in the EMS group and 28 patients in the control
group. Baseline characteristics of all patients in the EMS and
control groups have been previously reported [17]. Baseline
characteristicsofpatientsﬁnallyevaluatedinbothgroupsare
presented in Table 1.
The MRC scores of all the movements of the upper and
lower extremities assessed are presented in Table 2. Patients
of the EMS group performed statistically higher MRC scores
than controls in wrist ﬂexion, hip ﬂexion, knee extension,
and ankle dorsiﬂexion of both sides. No statistical diﬀerences
were found between the two groups in all other movements.
No signiﬁcant between-group diﬀerences were observed for
the MRC score of the left and the right arm either, while
the MRC scores of the left and right legs were signiﬁcantly
higherintheEMSgroup.Similarbetween-groupresultswere
found for the total MRC score of the arms (EMS: 28 (26–30);
control:26(22–30),P = 0.16)andthelegs(EMS:29(26–30);
control: 25 (20–28), P = 0.01). The overall MRC score was
signiﬁcantly higher in patients assigned to the EMS group in
comparison to the control group (58 (51–60) versus 52 (40–
58), P = 0.04) (Figure 2).4 Critical Care Research and Practice
Table 1: Baseline characteristics of the patients ﬁnally evaluated in the EMS group and the control group (mean ± SD; in medication
variables: median (25th–75th percentiles)).
EMS group Control group P
n 24 28
Age, years 55 ±20 59 ±21 0.49
Gender, male/female 19/5 22/6 >0.99
SOFA score on admission 8 ±38 ±30 . 5 2
APACHE II score on admission 16 ±41 9 ±50 . 0 3
SAPS III score on admission 55 ±11 58 ±14 0.34
Diagnostic category at admission
Brain injury, n (%) 9 (38%) 5 (18%)
Postsurgical, n (%) 7 (29%) 5 (18%)
Respiratory failure, n (%) 0 (0%) 2 (6%) 0.05
Sepsis/septic shock, n (%) 1 (4%) 10 (36%)
Trauma, n (%) 5 (21%) 5 (18%)
Other, n (%) 2 (8%) 1 (4%)
Comorbidities
Cardiovascular disease, n (%) 8 (33%) 13 (46%) 0.50
Diabetes mellitus, n (%) 3 (13%) 5 (18%) 0.71
GI disease, n (%) 3 (13%) 1 (4%) 0.32
Haematologic disease, n (%) 1 (4%) 1 (4%) >0.99
Hepatic disease, n (%) 2 (8%) 0 (0%) 0.21
Renal disease, n (%) 0 (0%) 6 (21%) 0.03
Respiratory disease, n (%) 3 (13%) 9 (32%) 0.18
Other, n (%) 2 (8%) 1 (4%) 0.59
None reported, n (%) 8 (33%) 8 (29%) 0.95
Sepsis during ICU stay, n (%) 16 (67%) 21 (75%) 0.72
Medication
Sedation, days 5 (2–10) 4 (2–9) 0.85
Aminoglycoside administration, days 0 (0–4) 1 (0–4) 0.18
Corticosteroid administration, days 0 (0–2) 0 (0–2) 0.96
NMBA administration, days 0 (0-0) 0 (0-0) 0.48
EMS: electrical muscle stimulation; SOFA: sequential organ failure assessment; APACHE: acute physiology and chronic health evaluation; SAPS: simpliﬁed
acute physiology; GI: gastrointestinal; NMBA: neuromuscular blocking agents.
In concern to the baseline characteristics of the subgroup
in which handgrip dynamometry was applied (n = 21), no
diﬀerence was found between the control (n = 9) and the
EMS group (n = 12) in gender (males/females, 6/3 versus
10/2, P = 0.61), age (65±22 versus 61±14 years, P = 0.25),
or APACHE II score (19 ±4v e r s u s1 7±4, P = 0.46).
No diﬀerence was observed between the EMS and the
control group in handgrip strength either in absolute (21.4±
10.8v e r s u s1 4 .8±10.7kg,resp.,P = 0.18) or relative (60.2±
27.3% predicted versus 49.1 ± 28.5% predicted, resp., P =
0.38) values. A signiﬁcant diﬀerence was found in handgrip
strength between patients diagnosed with ICU-AW in com-
parison to those without an ICU-AW diagnosis (6.6 ± 4.4
versus 23.4 ± 8.9kg,P<0.01), even when the comparison
was adjusted for gender and age (P<0.01). This was also the
case when handgrip performance was expressed in relative
values(29.0±22.4%predictedversus66.0±22.2%predicted,
P<0.01).
In concern to between-sides comparison, patients tended
to perform better with the dominant rather than the non-
dominant hand (16.2 ± 11.1v e r s u s1 4 .2 ± 9.9kg,resp.,P =
0.09). All patients assessed were right handed, therefore the
results were similar for comparison between right and left
sides.Threepatientsperformedbetterwiththelefthand,and
in another 3 patients, there was no diﬀerence between hands.
The 95% limits of agreement were also calculated and found
to range from −7.1 to 10.3kg.
In relation to between-trial comparisons, no diﬀerence
was observed over the 5 trials performed (1st: 16.1±10.5kg,
2nd: 16.8 ±10.8kg, 3rd: 16.9 ±11.5kg, 4th: 16.6 ±11.0, and
5th: 17.1 ±11.5kg,P = 0.44).
Finally, handgrip strength in absolute values correlated
(P<0.01) with the MRC score of upper extremities (r =
0.78), lower extremities (r = 0.73), and the overall (r =
0.79)MRCscores(Figure 3).Ther especti v ec orr elationc oef-
ﬁcients(P ≤ 0.01)forhandgripstrengthinrelativevalues(%
predicted) were 0.58, 0.53, and 0.55.Critical Care Research and Practice 5
Table 2: MRC scores of all the upper and lower extremities’ movements (median (25th–75th percentiles)). P values refer to between-group
comparisons for each movement.
EMS group Control group P
Left side
Shoulder abduction 4 (4-5) 4 (4-5) 0.41
Forearm ﬂexion 5 (4-5) 4 (4-5) 0.26
Wrist ﬂexion 5 (5-5) 5 (4-5) 0.03
Hip ﬂexion 4 (4-5) 4 (3–5) 0.05
Knee extension 5 (5-5) 4 (3–5) <0.01
Ankle dorsiﬂexion 5 (5-5) 5 (4-5) 0.04
Upper extremities (in total) 14 (12–15) 13 (11–15) 0.16
Lower extremities (in total) 14 (13–15) 12 (10–15) 0.02
Right side
Shoulder abduction 4 (4-5) 4 (3–5) 0.36
Forearm ﬂexion 5 (4-5) 4 (4-5) 0.19
Wrist ﬂexion 5 (5-5) 5 (3–5) 0.04
Hip ﬂexion 5 (4-5) 4 (3–5) 0.04
Knee extension 5 (5-5) 4 (3–5) <0.01
Ankle dorsiﬂexion 5 (4-5) 5 (4-5) 0.07
Upper extremities (in total) 14 (13–15) 13 (10–15) 0.17
Lower extremities (in total) 15 (13–15) 13 (10–14) 0.02
EMS: electrical muscle stimulation.
4. Discussion
The main ﬁnding of this posthoc analysis was that EMS
resulted in preserved strength, as evaluated with the MRC
scale, of directly stimulated muscle groups of the lower ext-
remities. Another ﬁnding was that EMS also resulted in
preserved strength of the wrist ﬂexors, a muscle group of the
upper extremities not stimulated.
4.1. EMS and Muscle Strength as Evaluated with the MRC
Scale. EMS preserved the strength of quadriceps and the
ankle dorsiﬂexors, which it was applied on. EMS application
was directly targeted at vastus medialis and lateralis and
longus peroneus, possibly aﬀecting other groups involved in
hip ﬂexion and ankle dorsiﬂexion. The improvement of
strength in muscle groups after EMS application has been a
consistent ﬁnding in CHF and COPD patients [11], COPD
[21], and septic patients [22] under mechanical ventilation,
as well as healthy populations [23], and could be explained,
at least to a large extent, by preservation of muscle mass [12,
16]. ICU patients are characterized by a catabolic state. EMS
has been shown to induce an anabolic stimulus in critically
ill [14] and postoperative patients [13]. Furthermore, in
recently published data of our group, the decrease of the
cross-sectional diameter of the rectus femoris and vastus
intermedius, a measure of muscle mass evaluated with ultra-
sonography, was lower in the EMS than the control group
after 8-day EMS sessions [16].
EMS also enhanced the strength of wrist ﬂexors, a muscle
groupinvolvedinupperlimbmovements,resultinginhigher
overall MRC score and strength in patients to whom it was
applied compared to controls. These ﬁndings collectively
p r o v i d es o m ee v i d e n c et oi m p l yas y s t e m i ce ﬀect of EMS in
muscle strength of critically ill patients. A likely explanation
could be the EMS eﬀects on pathophysiological mechanisms
involved in ICU-AW. The fact that EMS aﬀected wrist ﬂexors
but not shoulder abductors or forearm ﬂexors suggests some
kind of selectivity, which may be related to the size or the
characteristics of the muscle groups. The systemic eﬀects of
EMS on muscle strength need to be further investigated.
A potential factor relating EMS exercise and eﬀects—
local or systemic—in preservation of muscle strength may be
inﬂammation. The latter is associated with the development
of ICU-AW [6, 24]. Exercise, in general is known to exert
anti-inﬂammatory eﬀects [25], and this may be the case for
EMS [26, 27]. Another factor with a potential role in ICU-
AW development, which could be aﬀected by EMS appli-
cation, is microcirculation [3]. We have previously observed
an acute systemic eﬀect of lower extremities EMS on the
microcirculation of the thenar muscle, asassessed by near
infrared spectroscopy [15]. Karavidas et al. have also obser-
ved improved endothelial function in brachial artery after
EMS sessions of the legs in CHF patients [27]. Finally, other
factors EMS exercise might aﬀect in concern to ICU-AW are
mitochondrial function and release of antioxidant enzymes
[28, 29], as well as glucose oxidation [30].
EMS, as a possible substitute to aerobic and resistance
exercise training in severe CHF and COPD patients, has been
shown to improve muscle performance, aerobic exercise
capacity, and disease-speciﬁc health status [9–11, 21]. EMS
application in the ICU setting is directly related to the issue
of early rehabilitation and prevention. Recent studies suggest
that early rehabilitation is safe and feasible in ICU patients,
improving muscle strength, mobilization, aerobic capacity,
and ICU and hospital length of stay [7, 8, 31, 32]. However,
the vast majority of interventions demand patients’ active6 Critical Care Research and Practice
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participation. EMS exercise, in contrast, does not require
patients’ cooperation and can even be applied to sedated
patients.
4.2. Muscle Strength as Evaluated with Handgrip Dynamome-
try. In a subgroup of patients, no diﬀerences were observed
between the ones treated with EMS and controls in handgrip
strength whether expressed in absolute values or % pre-
dicted. The sample size however is possibly a confounding
factor for deﬁnite conclusions, as power analysis suggested.
A signiﬁcant diﬀerence was found in handgrip strength
between patients diagnosed with and without ICU-AW, even
whenresultswereadjustedforageandgender,factorsknown
to aﬀect strength performance [20]. In a previous study in
ICUpatients,asimilardiﬀerencewasfoundbetweenpatients
with and without ICU-acquired paresis, while handgrip
strength was independently associated with hospital mortal-
ity [33]. Handgrip strength may be a useful surrogate tool
for clinical diagnosis of ICU-AW, as it is easily administered
andprovidesobjectiveandquantiﬁedresults.Futureresearch
is needed for deﬁning proper reference values for ICU-AW
diagnosis, according to gender and age.
Standardization of the handgrip measurement is also
necessary. In this study, performance of the dominant hand
tended to be higher compared to the nondominant hand. In
addition, we did not ﬁnd any diﬀerences between the 5 trials.
Since the measurement can be aﬀected by movements other
than gripping, familiarization was included.
Handgrip strength correlated to the same extent with the
upper limbs, the lower limbs, and the overall MRC score,
reﬂecting the systemic character of ICU-AW and the accom-
panied muscle weakness. Correlation coeﬃcients of hand-
grip performance in absolute values are somewhat higher
than previously reported [33]; the diﬀerence however may
be related to the sample size. The fact that correlation
coeﬃcients of handgrip expressed in relative values are lower
than the respective coeﬃcients in absolute values further
emphasizes the necessity for developing norms according to
age and gender.
4.3. Limitations. The results of this study are limited by
the relatively small number of patients ﬁnally able to be
evaluated for ICU-AW. This is also a limiting factor in con-
cern to handgrip strength assessment. However, the results
are underpowered for deﬁnite conclusions. Another limita-
tion is the between-group diﬀerence in APACHE II score in
admission; however, no diﬀerences in other severity scores
were observed. Sham-EMS sessions were not applied to
the control group, and the MRC scale and handgrip inves-
tigators—though independent from each other—were not
blinded to patients’ group of randomization. Furthermore,
ICU staﬀ was not blinded due to absence of sham-EMS ses-
sions, and this may have aﬀected cointerventions. Finally, the
results might also have been aﬀectedby some between-group
diﬀerences in diagnosis upon ICU admission.
4.4. Clinical Implications. The results of this study imply that
EMS has a beneﬁcial eﬀect in the strength of muscle groups
stimulated. EMS of lower extremities may also have a sys-
temic eﬀect in the strength of muscle groups not stimulated
and the overall muscle strength of critically ill patients.
EMS also prevents ICU-AW development. EMS is safe, well-
tolerated and does not require patients’ cooperation, thus
presentingitselfasapotentialmeansforICU-AWprevention
as well as early rehabilitation and mobilization in ICU sett-
ing. Handgrip dynamometry, on the other hand, is a simple
and easy to administer measurement that could be a sur-
rogate tool in the clinical diagnosis of ICU-AW.
Future studies should focus on the EMS characteristics
abletooptimizetheeﬀectincriticallyillpatients.Inaddition,
theeﬀectsofEMSonthestrengthofmusclegroupsnotstim-
ulated, on respiratory muscle strength, and on additional
endpoints such as ICU and hospital length of stay, quality
of life, and health status after hospital discharge, need to be
investigated. Finally, the development of reference values in
relation to handgrip dynamometry would potentially aid in
ICU-AW diagnosis.
5. Conclusions
EMS exercise induces beneﬁcial eﬀects in muscle strength of
ICU patients. These eﬀects mainly concern muscle groups
directly stimulated, but there is also evidence of eﬀects in
muscle groups not stimulated. EMS application constitutes
a promising means of muscle strength preservation and early
mobilization in critically ill patients (ClinicalTrials.gov num-
ber: NCT 00882830).
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